A pregnant patient with a positive hepatitis B surface antigen

Area of Science:

• Hepatology
• Infectious Diseases
• Public Health

Background:

• Hepatitis B is a significant global cause of liver disease, with early-life infections leading to severe complications like cirrhosis and hepatocellular carcinoma.
• Worldwide efforts have focused on newborn immunization to combat chronic hepatitis B, with significant program expansion since 1992.
• Maternal screening and infant immunoprophylaxis have proven effective in reducing vertical transmission of the hepatitis B virus.

Purpose of the Study:

• To review the current management strategies for hepatitis B in pregnant populations.
• To identify and discuss the specific challenges encountered in managing hepatitis B during pregnancy.

Main Methods:

• Literature review of global hepatitis B vaccination programs.
• Analysis of strategies for maternal screening and infant immunoprophylaxis.
• Review of clinical management guidelines for hepatitis B in pregnant women.

Main Results:

• Global participation in hepatitis B vaccination programs for infants has increased dramatically from 31 countries in 1992 to 177 by 2009.
• Effective implementation of maternal screening and infant immunoprophylaxis has substantially decreased vertical transmission rates.
• Specific challenges in managing hepatitis B in pregnant patients require further investigation and tailored approaches.

Conclusions:

• Global vaccination initiatives have made substantial progress in controlling hepatitis B, particularly in preventing early-life infections.
• Reducing vertical transmission through maternal screening and infant immunoprophylaxis is a key success of public health interventions.
• Specialized management protocols are necessary to address the unique challenges of hepatitis B in pregnant individuals to ensure optimal outcomes for both mother and child.